Hanmi Pharm publishes GRI Standard-based 'CSR Report'
Hanmi Pharm publishes GRI Standard-based 'CSR Report'
  • Lee Kap-soo
  • 승인 2020.05.14 10:55
  • 댓글 0
이 기사를 공유합니다

Hanmi Pharm has published a "2019-20 Corporate Social Responsibility (CSR) report based on Global Reporting Initiative (GRI) Standard, an international standard for sustainability report and posted it on its website (www.hanmi.co.kr), a company spokesman said on May 13.

As the importance of corporate social roles has recently emerged, many companies have been pushing to publish GRI Standard-based sustainable management reports, while Hanmi Pharm was the first Korean pharmaceutical company to publish a CSR report in 2018. Hanmi Pharm then published a total of three consecutive reports until 2019 and 2020.

This year's CSR report of Hanmi Pharm consists of topics such as "R&D Management for New Challenges," "Challenges for Customer Satisfaction Management," "The Value of Respect for Ethical Management," "Human Resources Management," "Healthy and Safe Business Sites," EHS Management, shared growth, and win-win management.

Hanmi Pharm has decided to actively participate in the implementation of SDGs (Sustainable Development Goals) implemented by the UN and the international community, while regularly visualizing its non-financial information with the publication of CSR reports every year and releasing it on its website.

An official of the Korea Standards Association, who conducted a third-party verification of the report, said, "Hanmi Pharm is Korea's leading R&D-focused pharmaceutical company that focuses on creating global new drugs, and it is implementing CSV strategies that pursue corporate values through R&D and create social values based on them."

He added, "We hope that the publication of this report will actively inform stakeholders of the ESG performance of Hanmi Pharm, and take a step forward in achieving global sustainable development goals."

Meanwhile, Lim Jong-ho, executive director of Hanmi Pharm's CSR team, said, "As a pharmaceutical company that fulfills its social responsibilities, the core and goal of sustainable management are new drug development and R&D. We will create a virtuous circle in which innovative results generated by continuous R&D can lead to the realization of social values."

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. Chief Editorial Writer: Kim Hyoung-joong. CEO: Lee Kap-soo. Editor: Jung Yeon-jin.
  • Juvenile Protection Manager: Yeon Choul-woong. IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.